Jordyn Beamer

We'll provide you with Merrill investment insights. We'll help you explore the financial opportunities that exist in today's volatile stock markets.

[Jordyn Beamer @Jordynbeamer]

@GracieAgui75644 If you're interested, feel free to add me on WhatsApp—I'll send you plenty of stock market strategies.
https://t.co/TEhaF7YOj0

[Jordyn Beamer @Jordynbeamer]

@Andrew579496321 If you're interested, feel free to add me on WhatsApp—I'll send you plenty of stock market strategies.
https://t.co/TEhaF7YOj0

[Jordyn Beamer @Jordynbeamer]

@CatherineF71093 Of course! If you're interested, you can message me privately, and I can share some strategies to help you.

[Jordyn Beamer @Jordynbeamer]

$ATPC jumps to $5.82, up nearly 40% Traders are debating whether this is simply a Nasdaq compliance squeeze or the start of a real re-rating after the company finalized a major licensing deal that could reshape its growth outlook High-volatility setup here

[Jordyn Beamer @Jordynbeamer]

Market momentum remains orderly – $MSGM has risen 96% from $2.19 with strong trading volume.

Early entry yielded an ideal risk-reward ratio.

Currently, the price movements of $BITF and $ASST also indicate potential future price action.

[Jordyn Beamer @Jordynbeamer]

$QBTS is quantum-leaping again — and the particles are going wild! On April 15, D-Wave Quantum stock opened around $18.53, rocketed to a high of $20.40, and is trading near $20.12 (+18.56% intraday) with volume already exceeding 36 million shares — well above average.

[Jordyn Beamer @Jordynbeamer]

$RVMD just cured its own stock price blues with a miracle shot! On April 13, Revolution Medicines exploded +35.27% to trade around $130.45 (as of mid-morning), after opening near $132.41 and hitting a high of $135.81 before pulling back slightly to the $130–$131 zone.

[Jordyn Beamer @Jordynbeamer]

$FSLR attempting to work itself back into this lower range, trying for a double bottom here at demand

Watching for a move over the previous month high at 203.46 then we look towards then earnings gap starting at 215

[Jordyn Beamer @Jordynbeamer]

Early hesitation was real. $UGRO moved but didn’t convince, $PAVS stalled… then $EEIQ flipped everything. Once $NXTT joined, the pace changed and $ARTL $MGRX, $SST, $KOD, $FCHL, and $RMSG followed into a 511% surge.

[Jordyn Beamer @Jordynbeamer]

Everything about the current $ITOC move points to pressure and expansion.

Mark: $0.5259
Change: +84.48%
Volume: 34.79M live

The +75.55% gap from yesterday’s close has created a strong squeeze backdrop, and the Bollinger Bands are widening in response.

[Jordyn Beamer @Jordynbeamer]

$PLTR rket, up over 2% with the market largely down. DefendPalantir is showing impressive relative strength in pre-maing this green zone we have drawn up, once again.

[Jordyn Beamer @Jordynbeamer]

$ALB Downward Move Targeting $105-$80 Zone Primary scenario bearish. Alternative $225 if $206 breaks. Lithium correction still has significant room lower.

[Jordyn Beamer @Jordynbeamer]

Premarket Surges Don't Wait For Slow Traders Five stocks already up big before bell rings. Most retail enters wrong level at wrong time.

$AAPL $AMZN $HOOD $IREN $RKLB

[Jordyn Beamer @Jordynbeamer]

Volume building on a few tickers and price action starting to tighten near key levels. When these ranges break, momentum traders usually jump in quickly.
$IREN $RR $NB $OPEN $BBAI

[Jordyn Beamer @Jordynbeamer]

$UUUU one more rally to the upper boundary and you have a text-book cup & handle continuation. through its 50 DMA. Both oscillators negative. Another one where the 200 DMA seems likely.

[Jordyn Beamer @Jordynbeamer]

$ONDS $RCAT $AMPX $UMAC $AVAV $DPRO
Needham Names Top Drone Stocks to Buy as Unmanned Tech Boom Grows

[Jordyn Beamer @Jordynbeamer]

$PLTR rket, up over 2% with the market largely down. DefendPalantir is showing impressive relative strength in pre-maing this green zone we have drawn up, once again.

[Jordyn Beamer @Jordynbeamer]

$SRPT is a biopharmaceutical company focused on precision genetic medicine. ELEVIDYS is the first approved gene therapy for DMD, with TTM revenue of $2.41 billion (strong). Positive long-term data could drive sales growth and label expansion

[Jordyn Beamer @Jordynbeamer]

$USAR officially signed a non-binding LOI with the Commerce Dept’s CHIPS program for up to $1.6B of support, incl. $277M in proposed funding and a $1.3B, 15-year senior secured loan priced around Treasury +150 bps. It also priced a $1.5B PIPE at $21.50, expected to close Jan 28

[Jordyn Beamer @Jordynbeamer]

$ENGN is a clinical-stage biotechnology company with $193.7 million in cash reserves and recently secured $125 million in debt financing to provide additional runway, supporting operations until 2026. Support level: $11.60 Resistance level: $12.95